Brokers' take
Riverstone Holdings | Buy
Oct 5 close: S$1.655
Target price: S$2.12
Maybank Kim Eng Research, Oct 1
WE hosted a non deal roadshow (NDR) for Riverstone in Malaysia. Many institutional funds were already familiar with healthcare gloves but found Riverstone's dominance of the cleanroom-glove niche appealing. Investors particularly liked its above-average returns on equity (ROEs), margins and less demanding valuations than local peers.
Near-term positives are an earnings boost from a strong US dollar to Malaysian ringgit (USD…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Hong Kong regulator to probe PwC auditing role over Evergrande
US: S&P, Dow open flat as Middle East jitters ease, Netflix weighs on Nasdaq
DBS puts 46 HDB shops, private strata retail units on market for S$210 million
China to facilitate Hong Kong IPOs and expand Stock Connect
Global equity funds see surge in outflows as rate cut hopes fade
Gazelle Ventures makes cash offer for No Signboard shares at S$0.0021 apiece